Liver X receptors (LXR) a and b are important regulators of lipid homeostasis in liver, adipose and other tissues. However, no such information is available for the human placenta. We determined expression of both LXR a and b in placental trophoblast cell lines, BeWo and JAR. Exposure of BeWo cells to a synthetic LXR agonist, T0901317, resulted in an increase in the amount of mRNA of LXR target genes, sterol regulatory element-binding protein-1 and fatty acid synthase. T0901317 also increased the synthesis of lipids. Moreover, T0901317 resulted in a reduced secretion of hCG during differentiation of these cells. Our data for the first time demonstrate a new role for LXRs in the human placenta.
INTRODUCTION
Placental synthesis of hormones and transport of nutrients are critical for fetal growth and development [1] . Despite its importance in growth and development of the feto-placental unit, very little is known regarding regulation of fatty acid synthesis, transport and metabolism in the placenta [2] . Fatty acids are used by both the fetus and placenta to form triglyceride for energy stores, for membrane structure, to synthesize complex lipids, cell signaling, and gene expression [1, 2] . The placenta is composed of villi with highly specialized trophoblast cells, the villous trophoblasts, that form a barrier between the maternal uterus and fetus [3] . These cells are involved in the nutrient transport and metabolism in the human placenta [2] . The villous trophoblasts consist of cytotrophoblasts and syncytiotrophoblasts. The villous cytotrophoblasts proliferate and differentiate by fusion to form syncytiotrophoblasts that covers the entire surface of the villi [4] .
A sign of cytotrophoblast fusion in vitro is the increased production of the placental hormone hCG as syncytiotrophoblasts are the primary cells involved in placental hormone production. Placental synthesis of hCG is necessary for the maintenance of pregnancy in humans during the first trimester and it is directly involved in the stimulation of cytotrophoblast differentiation into the syncytiotrophoblast, in an autocrine process [5, 6] . Recently, peroxisome proliferator-activated receptor gamma (PPARg) and retinoid X receptors (RXR) have been shown to be involved in the regulation of hCG [7, 8] . hCG is a heterodimer comprising an alpha subunit (hCGa), common to all glycoprotein hormones, and a distinct beta subunit (hCGb) responsible for biological specificity of the hormone. PPARg/RXRa heterodimers directly increase the secretion and transcript levels of hCGb. Preliminary data indicate that elements located in the regulatory region of the hCGb gene bind RXRa/PPARg heterodimer suggesting that the heterodimer directly regulates human hCGb transcription [7, 8] . In human placenta, PPARg/RXRa heterodimers are functional units during cytotrophoblast differentiation into the syncytiotrophoblast in vitro. PPARg is also involved in cell differentiation of different cell types [8, 9] . Barak et al. [10] demonstrated that PPARg null mice die during embryogenesis because of interference of terminal differentiation of the trophoblast and placental vascularization. Unlike the PPARa knockout mice, PPARg knockout mice did not survive gestation and they had an embryonic lethal phenotype at day 10 of gestation [10] . Schaiff et al. [11] also reported, in trophoblasts cells, that two types of PPARg agonists have opposing effects, one promoting differentiation and the other hindering differentiation and promoting apoptosis. All these observations indicate that PPARg is involved in trophoblast differentiation.
Several transcription factors are known to regulate lipid flux, storage and utilization, of which some of the most important are SREBP, PPAR and LXR. The LXRs belong to a subclass of nuclear hormone receptors that form obligate heterodimers RXR and are bound and activated by oxidized derivatives of cholesterol [12, 13] . There are two known LXR isoforms; LXRa (NR1H3) and LXRb (NR1H2). LXRa is known to have a relative restricted expression pattern (liver, kidney, intestine, adipose tissue, adrenals and macrophages), whereas LXRb is ubiquitously expressed. RXR/LXR heterodimers activate their target genes by binding to specific responsive elements termed LXREs, consisting of a hexanucleotide direct repeat separated by four nucleotides (DR4) [14] .
Studies of LXR target genes in LXR deficient mice indicate a pivotal role for the LXRs in the regulation of hepatic bile acid synthesis and intestinal cholesterol absorption [15, 16] . LXRs have also been shown to be involved in cholesterol efflux and reverse cholesterol transport in macrophages and other peripheral tissues [17, 18] . In liver and adipose tissue, LXRs are involved in lipogenesis by direct regulation of key target genes, including SREBP-1c [19] , the master transcriptional regulator of fatty acid synthesis, and fatty acid synthase (FAS), a key enzyme in the de novo biosynthesis of fatty acids [20] . LXRa ÿ/ÿ knock out mice showed impaired expression of several hepatic genes while LXRb ÿ/ÿ knock out mice failed to the phenotype as observed in LXRa ÿ/ÿ knock out mice [21] . These studies indicated a more prominent role of LXRa than LXRb as a regulator of LXR target genes in hepatocytes.
Since the LXRs are key regulators of lipid metabolic signaling pathways in several tissues, these may also play an important role in lipid metabolism in placenta and thus may regulate lipid metabolism in pregnancy. Normal human pregnancies result in a pronounced physiologic hyperlipidemia involving a gestational rise in plasma lipids [22] . Hyperlipidemia is the most common complication of pregnancy, remains a source of maternalechild morbidity and mortality, however, the etiology of this disorder is still not understood. Maternal hyperlipidemia is a characteristic feature during pregnancy and corresponds to an accumulation of triglycerides not only in very low-density lipoprotein but also in low-and high-density lipoprotein. In preeclampsia, there is a further increase in plasma lipids compared to normal pregnancy [22, 23] . Maternal liver may play major roles in lipid homeostasis, however, placenta's role in the development of hyperlipidemia has been increasingly evident [24, 25] . As triglycerides do not cross the placental barrier, the presence of lipoprotein receptors in the placenta, together with lipoprotein lipase, phospholipase A 2 , and intracellular lipase activities, allows the release to the fetus of polyunsaturated fatty acids transported as triglycerides in maternal plasma lipoproteins. The expression of both VLDL and LDL receptor mRNAs was reduced in the placentas of women whose pregnancies were complicated by preeclampsia [26] . The decrease in these placental lipoprotein receptors may result in reduced receptor-mediated uptake of plasma lipoproteins by the placenta and hence a reduced clearance of these lipoproteins from the maternal plasma.
Placental regulatory proteins and their integration for maintenance of cholesterol and lipid homeostasis need to be maintained optimally for both the mother and the developing fetus [24, 25] . The presence of PPARs and RXRs in human trophoblasts and their importance in feto-placental development is reported [8e10]. However, no such information is available on LXRs and their roles in lipid metabolism in the placenta. In order to understand their role in placenta, we investigated LXRs in human placental trophoblast cells. In this study we have used BeWo as a model for lipid metabolism. BeWo cells are a good experimental model for placental trophoblasts to study lipid metabolism, as these cells express several lipid metabolic genes [27e31].
We demonstrate, for the first time, that both LXRa and LXRb are expressed in BeWo and JAR cells, and that they regulate expression of LXR target genes (FAS and SREBP) involved in lipogenesis. Moreover, we also report that the LXRs mediate inhibition of hCG secretion during trophoblast differentiation. Together these data indicate a potential role for the LXRs in the regulation of lipid metabolism and a possible involvement in differentiation of trophoblast cells. 
MATERIALS AND METHODS

Materials
Cell culture
The BeWo (p195) and JAR (p175) cell lines, human choriocarcinoma cell lines, were obtained from American Type Culture Collection (Manassas, USA). BeWo and JAR cells were maintained in HAM's F12 and RPMI-1640 medium, respectively. Both media were supplemented with 2 mM L-glutamine, penicillin (50 units/ml), streptomycin (50 mg/ml) and 10% heat-inactivated fetal bovine serum, and trypsinated approximately every 4th day. Cell cultures were maintained at 37 (C in a 5% CO 2 atmosphere. Differentiation of BeWo cells was performed by incubating the cells for 48 h with 100 mM forskolin. Differentiation efficiency was verified by measuring hCG secretion with ELISA (DRG Instruments, Germany). Cell viability was determined by measuring LDH (Roch, Mannheim, Germany).
Ligand treatment
Wherever necessary, BeWo cells were treated with different ligands (T0901317 or 22(R) hydroxycholesterol) dissolved in DMSO or vehicle (DMSO) as a control. These agents were added at the same time and subsequently incubated under identical experimental conditions.
RNA extraction and Northern blot analysis
Total RNA from BeWo or JAR cells was extracted with TRIzol Ò Reagent (Invitrogen, Paisley, UK) as recommended by the manufacturer. Total RNA (20 mg) was separated on a 1.5% agarose formaldehyde gel and blotted and hybridized as described previously [32] . Blots were hybridized with cDNA probes from human (h) and rat (r), rLXRa, hLXRb, hCG, rSREBP-1 and rFAS. Hybridization with the human ribosomal protein L27 (Manassas, USA) was used as a control for equal RNA loading. The membranes were probed with [a-
32 P]dCTP radiolabeled cDNA, prepared using Megaprime DNA labeling system (Amersham Biosciences, Inc., Buckinghamshire, UK). Specific activities from 2 to 6 ! 10 8 cpm/ mg DNA were used. The sizes of the mRNA transcripts were calculated on the basis of the migration of the 18 and 28 S rRNA, which were visualized by ethidium bromide. Northern blots were analyzed by phosphorimaging.
Transient transfection and luciferase assay
BeWo cells (20,000 cells/cm 2 ) were seeded in six-well plates. The cells were transfected using 4 ml LipofectamineÔ Reagent (Invitrogen, Carlsbad, USA) and 1.5 mg of 2 ! LXRE plasmid fused to a luciferase reporter gene (a gift from J.A. Gustafsson, Karolinska Institute, Sweden) and 100 ng pTK renilla luciferase (as a control of transfection efficiency). The transient transfection was carried out as recommended by the manufacturer. Three hours after transfection, cells were cultured in medium containing serum and incubated for 24 h in the same medium containing appropriate agents, as indicated. Cells were harvested in 250 ml reporter lyses buffer, and the luciferase activities were measured using the DualLuciferase Ò Reporter Assay System (Promega, Madison, USA) as recommended by the manufacturer.
Thin-layer chromatography (TLC)
BeWo cells (15,000 cells/cm 2 ) were seeded in six-well plates. After 24 h, these cells were stimulated with 1 mM T0901317 or with DMSO for 48 h. Medium was then replaced with serum free medium and incubated for 12 h prior (in order to reduce the amount of cellular lipids) to the addition of 100 mM Na acetic acid containing 1.5 mCi/ml [2-
14 C]acetic acid, and subsequently incubated for 8 h in serum free medium. Lipids were extracted from the medium using chloroform:methanol as described previously [33] . Total radioactivity was counted by liquid scintillation to determine the incorporation of radiolabeled acetic acid into lipids. In addition, incorporation of radioactivity into different lipid fractions (fatty acids, FA, monoacylglycerol, MAG, diacylglycerol, DAG, triacylglycerol, TAG, and phospholipids, PL) was determined by TLC analysis using hexane/diethyl ether/acetic acid (65:35:1, vol/ vol/vol) as solvent [33] . The various lipids were visualized by iodine, the TLC plates scraped and the samples were counted by liquid scintillation. Appropriate lipid standards were used for identification of lipids. Cells from each well were harvested in 400 ml distillated water and protein measured as an internal control.
ELISA of hCG
BeWo (9000 cells/cm 2 ) cells were seeded in six-well plates. After 72 h, the cells were then incubated with vehicle (DMSO) or increasing concentrations of T0901317, together with 100 mM of forskolin as indicated elsewhere. Medium was collected after incubation for 48 h. Free bhCG was then measured in the medium without concentration by ELISA, as recommended by the manufacturer (DRG Instruments GmbH, Germany).
Statistical analysis
Differences in 2 ! LXRE reporter gene activation were tested with independent samples T-test, and related confident intervals were calculated using Student T-distribution. The effect of different levels of T0901317 was studied by either linear regression on log scale (hCG) or linear regression on square root (SREBP-1 and FAS). Regarding the TLC lipid data, a mixed effect model [34] was used to account for the two independent experiments with unequal number of measurements. All calculations were done using either the R or SPSS statistical packages.
RESULTS
Expression of LXRs in trophoblast cell lines
Expression of LXR a and b genes was studied in undifferentiated and differentiated BeWo using Northern blot analyses ( Figure 1A) . Expression of LXRa and LXRb was also determined after differentiation of these cells with 100 mM forskolin for 48 h to form a syncytium. Syncytium formation was monitored by measuring hCG secretion (data not shown). A higher LXRb mRNA expression was observed in the differentiated BeWo cells compared to undifferentiated cells, whereas the reverse expression pattern was observed in the case of LXRa. JAR cells (undifferentiated) also showed the presence of LXR isomers.
BeWo cells were then transfected with a luciferase reporter construct containing 2 ! LXRE and incubated with 5 mM of an LXR oxysterol agonist 22(R) hydroxycholesterol [22(R) HC] and a synthetic selective LXR agonist T0901317 (1 mM) [35] . Consistent with the LXRa and LXRb mRNA data, there was an approximately 10-fold increase with T0901317 and a 6-fold increase with the 22(R) HC in reporter gene activity. This indicates that the BeWo cells contain endogenous LXR and RXR proteins that are able to transactivate LXR target genes ( Figure 1B) .
LXR mediated lipid synthesis and target genes
To investigate whether the LXRs are involved in lipid synthesis, BeWo cells were incubated with 14 C-acetate after stimulation with T0901317 for different time periods. An incubation for 8e10 h produced greatest increase in lipid synthesis (2.6-fold) when compared with those of untreated cells (data not shown). At 8 h there was a 2.5-to 4.5-fold statistically significant increase in FA, TAG and DAG (p ! 0.001) and PL/MAG (p ! 0.05) compared to untreated cells (Table 1) .
In order to explore whether LXR lipogenic target genes (SREBP-1 and FAS) were involved in increased synthesis of lipids, we examined the mRNA expression of SREBP-1 and FAS genes in BeWo cells under these conditions. A dose dependent increase in SREBP-1 and FAS expression was observed with increasing concentrations of T0901317. The highest expression of both SREBP-1 (7-fold) and FAS (5-fold, p-values for linear trend !0.00001) was observed at 0.1 mM of the agonist in undifferentiated cells (Figure 2A) . Similarly, the highest expression of both SREBP-1 (2-and 9-fold) and FAS (2-and 6-fold, p-values for linear trend !0.001) was observed at 0.1 mM of the agonist in differentiated cells ( Figure 2B ). Use of T0901317 at concentrations O0.1 mM did not produce further expression of these genes (data not shown). The SREBP-1 cDNA probe used in these Northern blot analyses does not distinguish between SREBP-1 and SREBP-1a. However, only SREBP-1c is shown to be induced by LXR agonists [19] , and is therefore likely to be the transcript observed in this study.
Effect on hCG production during cell differentiation
Since the level of hCG increases during differentiation of cytotrophoblasts to syncytiotrophoblasts, we wanted to examine if activated LXRs could affect hCG mRNA and protein synthesis during differentiation. Simultaneous incubation with T0901317 and forskolin throughout cell differentiation produced a dose dependent reduction of hCG mRNA transcript (p-value for trend !0.0001) ( Figure 3A ) and hCG secretion (p-value for trend !0.001) ( Figure 3B ).
DISCUSSION
We demonstrated that both LXRa and LXb genes are expressed in human placental trophoblast cell lines, BeWo and JAR, and these can be regulated by LXR agonist treatment. We further demonstrated that regulation of fatty acid synthesis is possibly mediated via LXR target genes in BeWo cells.
Placenta is metabolically active in lipid metabolism, and our data for the first time support such a regulatory role for LXR in placental trophoblasts. LXR has similar lipid metabolic effect in placenta as observed in liver and adipose tissues [19,35e37] .
The gene expression patterns of LXRa and LXRb mRNA in differentiated BeWo cells are not similar. LXRa was expressed in greater amounts in undifferentiated than in differentiated cells, while this was opposite for LXRb. In addition, LXRa but not LXRb mRNA expression was increased by T0901317 treatment in BeWo cells (data not shown). This indicates possible different metabolic roles yet unknown for the two isoforms of LXR in the cytotrophoblasts and syncytiotrophoblasts. However, this observation is not without precedent as differential expression of LXRa and LXRb genes is also observed in adipocytes and myoblasts. In contrast to BeWo cells, expression of LXRa in adipocytes and myoblasts was much more pronounced in differentiated cells compared with undifferentiated cells, whereas no such difference of gene expression of LXRb was observed [20, 37] . In LXRb deficient mice there was an increase in LXRa expression, while no such increase was seen in LXRb mRNA levels in LXRa deficient mice (unpublished data). This indicates that LXRb has the potential to regulate basal LXRa expression, and giving an explanation for a reduced expression of LXRa where LXRb is dominant as in BeWo cells. The physiological implications of these differential roles of LXR in placental biology are yet to be explored. Most recent data suggest that LXRb is involved in inhibitory effects of oxLDL on trophoblast invasion in vitro, however, mechanisms are not known yet [38] . LXR thus may play a role in preeclampsia, a condition in which lipid peroxidation is increased and invasion trophoblast cells are reduced.
Compared with the liver, placenta secretes 50e200 times more FA [39] , indicating the importance of FA as a mode of delivery of lipids to the fetus [2] . The increased FA secretion by BeWo cells mediated by LXRs indicates its importance in placental lipid transport. This important process is probably mediated at least in part by the LXR target genes SREBP-1 and FAS, as these genes were up-regulated by LXR agonist treatment in BeWo cells. The presence of SREBP-1 and FAS in human trophoblasts as well as in human fetal tissues was reported [40] . High levels of expression of these genes in human fetal tissues indicate their roles in proliferation in fetal tissues. It is therefore interesting to speculate that SREBP-1 and FAS have an important function in rapidly developing tissues like placenta where increased supply of lipids is required in order to support optimum fetal growth. LXR may play an important regulatory role in this regard.
It is interesting to note that a pathological increase in TAG and FA during pregnancy is an independent risk factor for the development of preeclampsia [41] . Preeclampsia is also associated with elevated plasma concentrations of oxidized low density lipoproteins (oxLDL) [42] . The receptors for oxLDL in trophoblast cells [18, 43] may supply oxysterols through uptake of lipoproteins containing oxLDL for activation of LXR [12, 18] and subsequent increased fatty acid synthesis. Fatty acid synthesized in the trophoblasts may opt for fetal or maternal circulation, or both. Our experimental conditions were designed to determine lipid synthesis by LXR agonist in these cells, not the lipid secretion [39] . Therefore at the present moment we cannot speculate whether increased synthesis of fatty acids contribute to the elevated maternal or fetal lipids. Further work is required using a transwell cell culture model to determine the contribution of placental lipids to maternal or fetal circulation.
LXRs significantly reduced hCG production in BeWo cells in contrast to PPARg which increased hCG secretion in a ligand specific way [8] . Complicating the picture, another study showed a different effect of PPARg on hCG production depending on which PPARg agonist was used [10, 11] . This is despite the fact that PPARg is important in the development of placenta [10] . Interestingly, there was an induction of LXRa transcript when BeWo cells were incubated with 1 mM of the synthetic PPARg ligand darglitazone (data not shown), indicating that LXRa is a PPARg target gene in these cells. LXRa is also observed to be a PPARg target gene in adipocytes [37] and in macrophages [44] . Although the mechanisms of LXR mediated inhibition of hCG secretion in BeWo cells is not known at present, we can speculate that LXRa may have a new regulatory role in trophoblasts, countervailing the effect of PPARg on hCG production and thereby contributing to balance the production of hCG during pregnancy. Recent observations indicate that apart from the activators of several lipogenic genes, LXRs are involved in down regulation of genes associated with carbohydrate metabolism and other functions [45e47] . Further work needs to be done to understand the mechanisms involved in inhibition of hCG secretion mediated by the LXRs in BeWo cells.
In conclusion, for the first time, we demonstrate that both LXR a and b are expressed in human trophoblast cell lines, and that these are involved in lipogenesis as well as inhibition of hCG production in BeWo cells. LXR may therefore play an important role, hitherto unknown, in fetoplacental biology.
